Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference where key issues in the management of these 2 disea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international 2017-03, Vol.91 (3), p.539-551
Hauptverfasser:	Goodship, Timothy H.J., Cook, H. Terence, Fakhouri, Fadi, Fervenza, Fernando C., Frémeaux-Bacchi, Véronique, Kavanagh, David, Nester, Carla M., Noris, Marina, Pickering, Matthew C., Rodríguez de Córdoba, Santiago, Roumenina, Lubka T., Sethi, Sanjeev, Smith, Richard J.H., Alpers, Charlie E., Appel, Gerald B., Ardissino, Gianluigi, Ariceta, Gema, Arici, Mustafa, Bagga, Arvind, Bajema, Ingeborg M., Blasco, Miguel, Burke, Linda, Cairns, Thomas D., Carratala, Mireya, D'Agati, Vivette D., Daha, Mohamed R., De Vriese, An S., Dragon-Durey, Marie-Agnès, Fogo, Agnes B., Galbusera, Miriam, Gale, Daniel P., Haller, Hermann, Johnson, Sally, Józsi, Mihály, Karpman, Diana, Lanning, Lynne, Le Quintrec, Moglie, Licht, Christoph, Loirat, Chantal, Monfort, Francisco, Morgan, B. Paul, Noël, Laure-Hélène, O'Shaughnessy, Michelle M., Rabant, Marion, Rondeau, Eric, Ruggenenti, Piero, Sheerin, Neil S., Smith, Jenna, Spoleti, Fabrizio, Thurman, Joshua M., van de Kar, Nicole C.A.J., Vivarelli, Marina, Zipfel, Peter F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals anti-complement therapies atypical hemolytic uremic syndrome Atypical Hemolytic Uremic Syndrome - drug therapy Atypical Hemolytic Uremic Syndrome - genetics Atypical Hemolytic Uremic Syndrome - immunology Atypical Hemolytic Uremic Syndrome - pathology C3 glomerulopathy complement Complement Activation - drug effects Complement C3 - genetics Complement C3 - immunology Complement Inactivating Agents - therapeutic use Genetic Predisposition to Disease glomerulonephritis Glomerulonephritis - drug therapy Glomerulonephritis - genetics Glomerulonephritis - immunology Glomerulonephritis - pathology Human health and pathology Humans Kidney - drug effects Kidney - immunology Kidney - pathology kidney disease Life Sciences Phenotype Risk Factors Treatment Outcome Urology and Nephrology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!